Agbeyewa Farms Limited, a leading agricultural company, has addressed recent allegations of land encroachment made against it ...
On Tuesday, Cassava Sciences Inc (SAVA) stock saw a decline, ending the day at $3.83 which represents a decrease of $-0.47 or -10.93% from the prior close of $4.3. The stock opened at $4.32 and ...
Research commissioned by the British Council in Ghana, Kenya, Nigeria, South Africa, Uganda, and Zimbabwe found several ...
Kenya’s new Mvua Press adds to a short, but growing, list of African independent publishers in a market where books, ...
BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for ...
Cassava Sciences' Phase 3 trial for Alzheimer's failed to meet primary or secondary endpoints, leading to the discontinuation ...
Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by ...
Where are the kids from Netflix's 'The Lost Children' now? They went missing in the Amazon jungle for 40 years. Here's where ...
Punchng on MSN2d
Senate pushes for 20% Cassava inclusion in flour productsThe Senate has passed for a second reading a bill that seeks the inclusion of 20 per cent high-quality cassava flour in wheat ...
The Nigerian Senate on Tuesday passed for second reading a bill aimed at promoting the inclusion of cassava in flour and its ...
Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...
Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trial and the stock plummeted ~90%. See why I changed my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback